Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Allergan plc

BIO Notebook: FDA User Fees For AI Regulation, Partnering Strategy Evolves, And More

Insights from Day Two of the BIO International Convention in San Diego include the evolving pros and cons of partnering, user fees potentially supporting the FDA's AI ambitions, and J&J's view on dealmaking in 2024.

BIO Artificial Intelligence

BIO Notebook: US FDA User Fees For AI Regulation, Partnering Strategy Evolves, And More

Insights from Day Two of the BIO International Convention in San Diego include user fees potentially supporting the FDA's AI ambitions, the evolving pros and cons of partnering, and J&J's view on dealmaking in 2024.

BIO Artificial Intelligence

Formycon’s Lucentis Biosimilar Enters Swiss and Canada Markets

Switzerland and Canada mark the first market entries for Formycon’s ranibizumab biosimilar this year, with several anticipated launches in the Middle East later in 2024.

Biosimilars Launches

Finance Watch: The Biggest Biopharma IPO Of 2024 May Not Happen In The US

Public Company Edition: Galderma proposed pricing for its $2.6bn Swiss public market debut. Also, Apogee and Akero lead follow-on offerings with $483m and $366.9m, respectively, and Lexicon’s private placement brings in $250m, while Spruce reveals a 21% workforce reduction.

Financing Growth
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • Actavis, Inc.
    • Actavis plc
    • Akarna Therapeutics Ltd.
    • Allergan Aesthetics
    • Allergan, Inc.
    • Anterios, Inc.
    • Arrow Group (Subsidiaries: Arrow Generics (U.K), Cobalt Group (U.S.))
    • AqueSys, Inc.
    • Bonti, Inc.
    • Chase Pharmaceuticals Corporation, Inc.
    • Durata Therapeutics
    • Elastagen Pty Ltd
    • EndoArt SA
    • Envy Medical, Inc.
    • Forest Laboratories [Aptalis Pharmaceutical Technologies
    • (Axcan Pharma, Inc.
    • Eurand N.V.
    • Mpex Pharmaceuticals, Inc.)
    • Cerexa, Inc.
    • Clinical Data, Inc.]
    • Furiex Pharmaceuticals, Inc. (PPD, Inc.)
    • Kythera Biopharmaceuticals, Inc.
    • MAP Pharmaceuticals
    • Motus Therapeutics, Inc. (Rhythm Health, Inc.)
    • Naurex, Inc.
    • Oculeve
    • Regado Biosciences, Inc.
    • RetroSense Therapeutics, LLC
    • Silom Medical Company
    • Uteron Pharma SA
    • Warner Chilcott PLC (Galen Holdings PLC)
    • Watson Pharmaceuticals, Inc.
    • Tobira Therapeutics, Inc.
    • Topokine Therapeutics
    • Vitae Pharmaceuticals, Inc.
    • ForSight VISION5, Inc.
    • LifeCell Corporation
    • ZELTIQ Aesthetics, Inc.
    • Zonagen, Inc.
    • Repros Therapeutics, Inc.
UsernamePublicRestriction

Register